21st ANNUAL EARLY HEARING DETECTION & INTERVENTION CONFERENCE
March 13 - 15, 2022 • Cincinnati, OH
Respiratory distress syndrome (RDS), also known as hyaline membrane disease, is a lung disease, which is the most common respiratory disease in babies born prematurely. It is caused when an infant does not produce sufficient amounts of surfactant, leading to collapsing of the lungs and low lung volumes. Treatment for RDS includes oxygen therapy, high frequency jet ventilation, mechanical ventilation, or a nasal continuous airway pressure machine. Further treatments such as extracorporeal membrane oxygenation are used if necessary. Respiratory distress syndrome can lead to further complications such as severe neonatal respiratory failure, lung disease and infections. Several studies have shown the effects of hearing loss in infants with respiratory distress syndrome. The type of hearing loss has shown to be consistently a sloping, sensorineural hearing loss, with hearing thresholds poorer in the higher frequencies, that is either progressive or late onset in nature. Infants with RDS are at a higher risk of acquiring a hearing impairment due to the extended risk factors that these infants face. Therefore, it is important that screening for hearing loss in this population throughout development, is stressed. It is important that physicians and parents are aware that the child’s hearing should be monitored.
- Discuss prevalence of hearing loss in children with respiratory distress syndrome
- Identify risk factors at birth associated with hearing loss
- Describe best practices for monitoring hearing loss in children with respiratory distress syndrome
No relevant financial relationship exist.
No relevant nonfinancial relationship exist.